❓ The question seeks data on admissions to WA child and adolescent mental health facilities due to illicit stimulant-induced psychosis, broken down by substance type and year. The answer provides the requested data with clarifying notes regarding data collection and categorization.
AnsweredQoN 4208Legislative Council
QuestionView source ↗
(1) How many patients, diagnosed with illicit stimulant-induced psychosis, have been admitted to child and adolescent mental health in-patient facilities across Western Australia between - (a) 1 July 2003 - 30 June 2004; (b) 1 July 2004 - 30 June 2005; and (c) 1 July 2005 - 30 June 2006? (2) Of those referred to in (1), how many admissions were due in part or whole as a result of - (a) cannabis; (b) amphetamines, including meth-amphetamine; (c) heroin; (d) cocaine; and (e) other?
(b) 1 July 2004 - 30 June 2005; and (c) 1 July 2005 - 30 June 2006?
(c) 1 July 2005 - 30 June 2006?
(b) amphetamines, including meth-amphetamine; (c) heroin; (d) cocaine; and (e) other?
(c) heroin; (d) cocaine; and (e) other?
(d) cocaine; and (e) other?
(e) other?
(b) 1 July 2004 - 30 June 2005 - 6 (c) 1 July 2005 - 30 June 2006 - 6 (2) 1 July 2003 - 30 June 2004 (a) 7 (b) 1 (c) Nil. (d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) 1 July 2005 - 30 June 2006 - 6 (2) 1 July 2003 - 30 June 2004 (a) 7 (b) 1 (c) Nil. (d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(2) 1 July 2003 - 30 June 2004 (a) 7 (b) 1 (c) Nil. (d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 7 (b) 1 (c) Nil. (d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 1 (c) Nil. (d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) Nil. (d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 1 July 2004 - 30 June 2005; and (c) 1 July 2005 - 30 June 2006?
(c) 1 July 2005 - 30 June 2006?
(b) amphetamines, including meth-amphetamine; (c) heroin; (d) cocaine; and (e) other?
(c) heroin; (d) cocaine; and (e) other?
(d) cocaine; and (e) other?
(e) other?
(b) 1 July 2004 - 30 June 2005 - 6 (c) 1 July 2005 - 30 June 2006 - 6 (2) 1 July 2003 - 30 June 2004 (a) 7 (b) 1 (c) Nil. (d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) 1 July 2005 - 30 June 2006 - 6 (2) 1 July 2003 - 30 June 2004 (a) 7 (b) 1 (c) Nil. (d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(2) 1 July 2003 - 30 June 2004 (a) 7 (b) 1 (c) Nil. (d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 7 (b) 1 (c) Nil. (d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 1 (c) Nil. (d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) Nil. (d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(d) Nil. (e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(e) 4 1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
1 July 2004 - 30 June 2005 (a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 4 (b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) Nil. (c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) Nil. (d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(d) Nil. (e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(e) 3 1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
1 July 2005 - 30 June 2006 (a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 3 (b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 3 (c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) Nil. (d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(d) Nil. (e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(e) 1 Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
Notes: 1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
The specific drugs listed in the question are not able to be individually identified for the first three categories.
AnswerView source ↗
Answered
14 November 2006
Responded by
Parliamentary Secretary representing the Minister for Health
Response time
21 days
(1) (a) 1 July 2003 - 30 June 2004 - 12
(b) 1 July 2004 - 30 June 2005 - 6
(c) 1 July 2005 - 30 June 2006 - 6
(2) 1 July 2003 - 30 June 2004
(a) 7
(b) 1
(c) Nil.
(d) Nil.
(e) 4
1 July 2004 - 30 June 2005
(a) 4
(b) Nil.
(c) Nil.
(d) Nil.
(e) 3
1 July 2005 - 30 June 2006
(a) 3
(b) 3
(c) Nil.
(d) Nil.
(e) 1
Notes:
1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug.
2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown.
3. The categories used in responding to question 2 are:
2(a) cannabinoids including cannabis
2(b) stimulants, including amphetamine and methamphetamine
2(c) opioids, including heroin.
The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 1 July 2004 - 30 June 2005 - 6
(c) 1 July 2005 - 30 June 2006 - 6
(2) 1 July 2003 - 30 June 2004
(a) 7
(b) 1
(c) Nil.
(d) Nil.
(e) 4
1 July 2004 - 30 June 2005
(a) 4
(b) Nil.
(c) Nil.
(d) Nil.
(e) 3
1 July 2005 - 30 June 2006
(a) 3
(b) 3
(c) Nil.
(d) Nil.
(e) 1
Notes:
1. The number of persons in the answers to question 2 may exceed the total in question 1, as a person may be admitted on another occasion with psychosis caused by a different drug.
2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown.
3. The categories used in responding to question 2 are:
2(a) cannabinoids including cannabis
2(b) stimulants, including amphetamine and methamphetamine
2(c) opioids, including heroin.
The specific drugs listed in the question are not able to be individually identified for the first three categories.
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.
Explore more
Government Gazette
Appointments, regulatory notices, planning changes.
Hansard
Debates, questions, speeches and sentiment.
Tabled Papers
Reports and documents tabled in Parliament.
Committees
Committee profiles and recent reports.
Regulations
Subsidiary legislation with filters and summaries.
Bills
Proposed laws and parliamentary progress.
Acts
Current WA legislation and summaries.
Explanatory Memoranda
Bills with EMs (text/PDF) available.
Members
MP profiles, party breakdown and rankings.
Pollie Rankings
Data-driven rankings across 19 categories.
Amendment Chains
Track how schemes and regulations evolve over time.